» Articles » PMID: 20147318

Genetic Variants in ABO Blood Group Region, Plasma Soluble E-selectin Levels and Risk of Type 2 Diabetes

Overview
Journal Hum Mol Genet
Date 2010 Feb 12
PMID 20147318
Citations 87
Authors
Affiliations
Soon will be listed here.
Abstract

Blood soluble E-selectin (sE-selectin) levels have been related to various conditions such as type 2 diabetes. We performed a genome-wide association study among women of European ancestry from the Nurses' Health Study, and identified genome-wide significant associations between a cluster of markers at the ABO locus (9q34) and plasma sE-selectin concentration. The strongest association was with rs651007, which explained approximately 9.71% of the variation in sE-selectin concentrations. SNP rs651007 was also nominally associated with soluble intracellular cell adhesion molecule-1 (sICAM-1) (P = 0.026) and TNF-R2 levels (P = 0.018), independent of sE-selectin. In addition, the genetic-inferred ABO blood group genotypes were associated with sE-selectin concentrations (P = 3.55 x 10(-47)). Moreover, we found that the genetic-inferred blood group B was associated with a decreased risk (OR = 0.44, 0.27-0.70) of type 2 diabetes compared with blood group O, adjusting for sE-selectin, sICAM-1, TNF-R2 and other covariates. Our findings indicate that the genetic variants at ABO locus affect plasma sE-selectin levels and diabetes risk. The genetic associations with diabetes risk were independent of sE-selectin levels.

Citing Articles

Association of blood group types and clinico-pathological features of gynecological cancers (GCs).

Aga S, Khan M, Al Mansour M, Hasosah R, Alsubaie L, Alfaify D BMC Cancer. 2025; 25(1):137.

PMID: 39849419 PMC: 11760766. DOI: 10.1186/s12885-025-13527-z.


ABO blood types and head and neck cancer: a systematic review with meta-analysis of observational studies.

Shi H, Yao J, Jiang C, Xu W, Jiang Z, Chen Y BMJ Open. 2024; 14(10):e088016.

PMID: 39414296 PMC: 11481122. DOI: 10.1136/bmjopen-2024-088016.


Targeting hematologic malignancies by inhibiting E-selectin: A sweet spot for AML therapy?.

Uy G, DeAngelo D, Lozier J, Fisher D, Jonas B, Magnani J Blood Rev. 2024; 65:101184.

PMID: 38493006 PMC: 11051645. DOI: 10.1016/j.blre.2024.101184.


Relationship Between ABO Blood Group and Microsatellite Instability in Colorectal Cancer: A Retrospective Single-Center Study.

Karaoglan B, Akyol C, Unal A, Kuzu A, Savas B, Utkan G J Gastrointest Cancer. 2023; 55(1):281-286.

PMID: 37414939 DOI: 10.1007/s12029-023-00958-9.


An atlas of genetic scores to predict multi-omic traits.

Xu Y, Ritchie S, Liang Y, Timmers P, Pietzner M, Lannelongue L Nature. 2023; 616(7955):123-131.

PMID: 36991119 PMC: 10323211. DOI: 10.1038/s41586-023-05844-9.


References
1.
Wolpin B, Chan A, Hartge P, Chanock S, Kraft P, Hunter D . ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst. 2009; 101(6):424-31. PMC: 2657095. DOI: 10.1093/jnci/djp020. View

2.
Pai J, Pischon T, Ma J, Manson J, Hankinson S, Joshipura K . Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med. 2004; 351(25):2599-610. DOI: 10.1056/NEJMoa040967. View

3.
Hwang S, Ballantyne C, Sharrett A, Smith L, Davis C, Gotto Jr A . Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation. 1998; 96(12):4219-25. DOI: 10.1161/01.cir.96.12.4219. View

4.
Stranges S, Rafalson L, Dmochowski J, Rejman K, Tracy R, Trevisan M . Additional contribution of emerging risk factors to the prediction of the risk of type 2 diabetes: evidence from the Western New York Study. Obesity (Silver Spring). 2008; 16(6):1370-6. DOI: 10.1038/oby.2008.59. View

5.
Thorand B, Baumert J, Chambless L, Meisinger C, Kolb H, Doring A . Elevated markers of endothelial dysfunction predict type 2 diabetes mellitus in middle-aged men and women from the general population. Arterioscler Thromb Vasc Biol. 2005; 26(2):398-405. DOI: 10.1161/01.ATV.0000198392.05307.aa. View